0001193125-14-226022.txt : 20140624 0001193125-14-226022.hdr.sgml : 20140624 20140604184104 ACCESSION NUMBER: 0001193125-14-226022 CONFORMED SUBMISSION TYPE: 497 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140605 DATE AS OF CHANGE: 20140604 EFFECTIVENESS DATE: 20140605 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iSHARES INC CENTRAL INDEX KEY: 0000930667 IRS NUMBER: 510396525 STATE OF INCORPORATION: MD FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 497 SEC ACT: 1933 Act SEC FILE NUMBER: 033-97598 FILM NUMBER: 14892137 BUSINESS ADDRESS: STREET 1: 400 HOWARD STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: (415) 670-2000 MAIL ADDRESS: STREET 1: 400 HOWARD STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: ISHARES INC DATE OF NAME CHANGE: 20000516 FORMER COMPANY: FORMER CONFORMED NAME: WEBS INDEX FUND INC DATE OF NAME CHANGE: 19970211 FORMER COMPANY: FORMER CONFORMED NAME: FOREIGN FUND INC DATE OF NAME CHANGE: 19950524 0000930667 S000004263 iShares MSCI Belgium Capped ETF C000011967 iShares MSCI Belgium Capped ETF EWK 497 1 d736343d497.htm FORM 497 FOR ISHARES INC Form 497 for iShares Inc

iShares®

iShares, Inc.

Supplement dated June 5, 2014

to the Summary Prospectus, Prospectus

and Statement of Additional Information (the “SAI”)

dated December 30, 2013 for the

iShares MSCI Belgium Capped ETF (the “Fund”)

The information in this Supplement updates information in, and should be read in conjunction with, the Summary Prospectus, Prospectus and SAI for the Fund.

Effective June 5, 2014, the number of shares in a Creation Unit and the approximate value of one Creation Unit of the Fund is as follows:

 

Fund

    Creation Unit
Size		      Approximate Value of a
Creation Unit as of
June 4, 2014		  

iShares MSCI Belgium Capped ETF

      80,000       $ 1,400,000   

If you have any additional questions, please call 1-800-iShares (1-800-474-2737).

 

iShares® is a registered trademark of BlackRock Fund Advisors or its affiliates.

  

     IS-A-EWK-0614   

 

 

PLEASE RETAIN THIS SUPPLEMENT

FOR FUTURE REFERENCE